HVAD™ performance tracker
Clinical experience with modified controller software
References to the “modified controller” refer to the alternate pump start algorithm within the controller software that may be able to restart a pump if the standard controller is unsuccessful in restarting a stopped pump (the availability of this alternate pump start algorithm was communicated via an urgent medical device communication in June 2022). The software in the modified controller has not been approved as being safe or effective for use by the US Food and Drug Administration or any other regulatory authorities, which means it has not been tested to the same level as software in an approved medical device and comes with risk. As such, the modified controller with unapproved software is not available in all geographies. The modified controller should only be used if the pump has stopped, and the standard, commercially available controller is unsuccessful at restarting the pump.
As of December 31, 2024, there has been 30 instances where a controller with the modified algorithm has been used in an attempt to restart an HVAD™ pump. The pump restarted in 23 of the 30 instances. Of the 23 restarts, two (2) were subgroup 2 patients, six (6) were subgroup 3 patients, and fifteen (15) were general population patients (not in one of the subgroups). No adverse events have been reported or evidence provided that use of the controller with the modified algorithm has impacted the patient and/or their pump within the 23 successful use cases.
For the seven (7) unsuccessful use cases, one (1) involved a subgroup 2 patient, two (2) involved subgroup 3 patients, and four (4) involved general population patients. The clinical information is as follows:
It is not known if any of these results will be typical or representative.